Your Advocates Ltd’s Merck MRK Stock Holding History

Your Advocates Ltd’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-240	Closed	-$27.7K	–	332
2023 Q2	$27.7K	Buy	+240	New	+$27.3K	0.01%	78

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Your Advocates Ltd's MRK Position: Q3 2023 in Review

Your Advocates Ltd sold out of Merck (MRK) in Q3 2023, closing a stake of 240 shares — an estimated $27.7K sold.

Your Advocates Ltd first reported a position in MRK in Q2 2023 and held it in 1 quarter. The position peaked at $27.7K in Q2 2023. 3,214 funds tracked by Wall St. Rank hold MRK as of Q3 2023.

Your Advocates Ltd reported no remaining Merck position as of Q3 2023 after selling out during the quarter.
Your Advocates Ltd sold 240 Merck shares in Q3 2023, an estimated $27.7K.
Your Advocates Ltd first reported a position in Merck in Q2 2023 and held it in 1 quarter.
Your Advocates Ltd's Merck position peaked at $27.7K in Q2 2023.
3,214 funds tracked by Wall St. Rank held Merck as of Q3 2023.

Based on Your Advocates Ltd's 13F filing for Q3 2023, filed 2 Nov 2023.